Search for more clinical trials
Tumor Bank for Tissue Samples
Conditions
Ovarian Neoplasms - Breast Neoplasms - Colorectal Neoplasms - Neoplasms of the Female Genitalia - Lung Neoplasms - Endocrine Gland Neoplasms
Conditions: official terms
Breast Neoplasms - Colorectal Neoplasms - Endocrine Gland Neoplasms - Lung Neoplasms - Neoplasms - Ovarian Neoplasms
Conditions: Keywords
Breast cancer, Ovarian cancer, Endometrium carcinoma, Cervix carcinoma,, Mamma carcinoma,, Prostata carcinoma, Colon carcinoma, Rectal carcinoma, Bronchus carcinoma, NSCLC (non small cell lung cancer) & SCLC (small cell lung cancer), Prostate carcinoma
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case Control
Intervention
Name: Tumor tissue collection
Type: Other
Name: Sampling of ascites and pleural effusion
Type: Other
Name: Collecting urine samples
Type: Other
Name: Collecting saliva sample
Type: Other
Name: Collecting sputum
Type: Other
Name: Collecting stool samples
Type: Other
Name: Lavage/Irrigation
Type: Other
Overall Status
Recruiting
Summary
Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank.
This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".
This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".
Detailed Description
Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to translational research. The relevance of "translational oncology" will only increase in the future -"From bench to bedside" - the swift implementation of new science research results in clinical studies in order to expedite progress in clinical cancer therapy for the benefit of the patient.
Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research.
The aim of this tumor bank is to consist of biological samples (together with a blood bank - see NCT01763125) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).
Its almost a matter of course in the medical science today to collect biological samples together with clinical information thereby creating the foundation for future excellent fundamental research.
The aim of this tumor bank is to consist of biological samples (together with a blood bank - see NCT01763125) and isolates of tumor patients and healthy people as controls. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank. The content of the tumor bank can provide essential material for current and future research (e.g. analyses of prognostic or predictive tumor markers; genetically analysis (polymorphism, mutation, hypermethylation; verification and characterisation of disseminated tumor cells).
Criteria for eligibility
Healthy Volunteers: Accepts Healthy Volunteers
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:
- Male/Female
- Age 18 to 90 years max.
- Just one current known malignant disease or just one current inflammatory disease
Exclusion Criteria:
- Inflammatory disease and malignant disease
- multiple malignancies
- multiple diseases
- underage
- Male/Female
- Age 18 to 90 years max.
- Just one current known malignant disease or just one current inflammatory disease
Exclusion Criteria:
- Inflammatory disease and malignant disease
- multiple malignancies
- multiple diseases
- underage
Locations
University Hospitals Leuven - Department of Obstetrics and Gynaecology
Leuven, Belgium
Charité University - Campus Virchow Chlinic
Status: Recruiting
Contact: Ignace Vergote, Prof.Dr. - +32/1634 - ignace.vergote@uzleuven.be
Berlin, Germany
Status: Recruiting
Contact: Jalid Sehouli, Prof.Dr. - Jalid.Sehouli@charite.de
Start Date
September 2003
Completion Date
January 2017
Sponsors
Medical University of Vienna
Source
Medical University of Vienna
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page